Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Saara Rannanpää"'
Autor:
Heidi Taipale, Markku Lähteenvuo, Antti Tanskanen, Saara Huoponen, Saara Rannanpää, Jari Tiihonen
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Due to its relatively high prevalence and recurrent nature, depression causes a major burden on healthcare systems, societies and individuals. Our objective was to investigate healthcare resource utilization and costs associated w
Externí odkaz:
https://doaj.org/article/dca968922cf34726b1c3fe0eb3906933
Publikováno v:
BMC Neuroscience, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background The treatment of Parkinson’s disease is often complicated by levodopa-induced dyskinesia (LID). Nicotinic acetylcholine receptor agonists can alleviate LID in animal models but may be less effective in conditions of severe dopam
Externí odkaz:
https://doaj.org/article/f2833f74947d4bff9346c9681eb8fc45
Autor:
Heidi Taipale, Markku Lähteenvuo, Antti Tanskanen, Saara Huoponen, Saara Rannanpää, Jari Tiihonen
Publikováno v:
BMC psychiatry. 22(1)
Background Due to its relatively high prevalence and recurrent nature, depression causes a major burden on healthcare systems, societies and individuals. Our objective was to investigate healthcare resource utilization and costs associated with treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b16820f582782779112cac9d41bb82eb
https://pubmed.ncbi.nlm.nih.gov/35854248
https://pubmed.ncbi.nlm.nih.gov/35854248
Publikováno v:
Journal of affective disorders. 308
Investigate incidence, risk factors and courses of treatment for treatment-resistant depression (TRD) in primary and special healthcare.All patients identified from nationwide registers, aged 16-65 years, diagnosed with depression in Finland during 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f885dbea590e2273f6e5c7fe1b67e3
https://pubmed.ncbi.nlm.nih.gov/35398108
https://pubmed.ncbi.nlm.nih.gov/35398108
Autor:
Mari Savolainen, T. Petteri Piepponen, Jaakko Kopra, Michael F. Salvatore, Saara Rannanpää, Jaan-Olle Andressoo, Timo T. Myöhänen, Marian Villarta-Aguilera, Samo Weingerl
Publikováno v:
Neuropharmacology. 128:221-230
Addictive drugs enhance dopamine release in the striatum, which can lead to compulsive drug-seeking after repeated exposure. Glial cell line-derived neurotrophic factor (GDNF) is an important regulator of midbrain dopamine neurons, and may play a mec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5522c19a8a2366530d3ee8eef9f114ef
https://doi.org/10.1016/j.neuropharm.2017.10.010
https://doi.org/10.1016/j.neuropharm.2017.10.010
Autor:
Saara Rannanpää, Annika Hultén
Publikováno v:
Journal for Reproducibility in Neuroscience. 2:1469
There is consensus within the scientific community that replication studies are scientifically sound and bring added value and reliability to any discovery. It is also widely acknowledged that replications are not as common as they perhaps should be.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c18f6a695b2727599c08d636b0a93911
https://doi.org/10.31885/jrn.2.2021.1469
https://doi.org/10.31885/jrn.2.2021.1469
Publikováno v:
Neuroscience Letters. 729:134932
The brain histaminergic and dopaminergic systems closely interact, and some evidence also suggests significant involvement of histamine in Parkinson’s disease (PD), where dopaminergic neurons degenerate. To further investigate histamine-dopamine in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f473eb467d979c8bff7230c3b4107e
https://doi.org/10.1016/j.neulet.2020.134932
https://doi.org/10.1016/j.neulet.2020.134932
Publikováno v:
BMC Neuroscience
BMC Neuroscience, Vol 19, Iss 1, Pp 1-10 (2018)
BMC Neuroscience, Vol 19, Iss 1, Pp 1-10 (2018)
Background The treatment of Parkinson’s disease is often complicated by levodopa-induced dyskinesia (LID). Nicotinic acetylcholine receptor agonists can alleviate LID in animal models but may be less effective in conditions of severe dopaminergic d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86583972169f281f1cea9686b8e5e681
https://doi.org/10.1186/s12868-018-0478-0
https://doi.org/10.1186/s12868-018-0478-0
Autor:
Saara Rannanpää, Tuukka Tapanainen, Outi Salminen, Sini K. Koski, Raisa Hänninen, Sakari Leino
Preclinical studies suggest the involvement of various subtypes of nicotinic acetylcholine receptors in the pathophysiology of Parkinson's disease, a neurodegenerative disorder characterized by the death of dopaminergic neurons in the substantia nigr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85cee0c1ed570f8c62dfb90725ccac04
http://hdl.handle.net/10138/253492
http://hdl.handle.net/10138/253492
Autor:
Sakari Leino, Outi Salminen, Louis-Eric Trudeau, Charles Ducrot, Saara Rannanpää, Marie-Josée Bourque, Vania F. Prado, Marco A. M. Prado, Rafael K. Varaschin, Guillaume Osterstock
Publikováno v:
Anatomy and Cell Biology Publications
Histamine H-3 receptors are widely distributed Gi-coupled receptors whose activation reduces neuronal activity and inhibits release of numerous neurotransmitters. Although these receptors are abundantly expressed in the striatum, their modulatory rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f346eff8208a4b9357021d3116a9b5d
http://hdl.handle.net/10138/308732
http://hdl.handle.net/10138/308732